We hypothesized that one plausible mechanism for the inhibition of β-catenin signaling might be its interference with LGR5 expression, since LGR5 has been shown to be an essential part of a complex that potentiates β-catenin signaling in colon cancer cells [21]. The gene discussed is LGR5; the disease is colonic neoplasm.